Article info
Laboratory science
Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features
- Correspondence to Robert M M Verdijk, Department of Pathology, Erasmus MC-University Medical Center, Rotterdam, The Netherlands, PO Box 2040, Rotterdam 3000CA, The Netherlands; r.verdijk{at}erasmusmc.nl/ j.vanipenburg{at}erasmusmc.nl
Citation
Prognostic value of TERT promoter mutations in conjunctival melanomas in addition to clinicopathological features
Publication history
- Received July 4, 2020
- Revised September 29, 2020
- Accepted October 8, 2020
- First published October 30, 2020.
Online issue publication
September 22, 2021
Article Versions
- Previous version (30 October 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.